Observational studyBMJ open2026

Real-world changes in lipid-lowering therapy use and LDL-C goal attainment in high and very high cardiovascular risk patients in the UK: a secondary analysis of the European SANTORINI study 1-year follow-up.

Derek Connolly et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.